Original Research

District and sub-district analysis of cryptococcal antigenaemia prevalence and specimen positivity in KwaZulu-Natal, South Africa

Naseem Cassim, Lindi M. Coetzee, Nelesh P. Govender, Deborah K. Glencross
African Journal of Laboratory Medicine | Vol 7, No 1 | a757 | DOI: https://doi.org/10.4102/ajlm.v7i1.757 | © 2018 Naseem Cassim, Lindi M. Coetzee, Nelesh P. Govender, Deborah K. Glencross | This work is licensed under Other
Submitted: 18 January 2018 | Published: 11 October 2018

About the author(s)

Naseem Cassim, Department of Haematology and Molecular Medicine, University of the Witwatersrand, Johannesburg South Africa; and, National Priority Programme, National Health Laboratory Service, Johannesburg,, South Africa
Lindi M. Coetzee, Department of Haematology and Molecular Medicine, University of the Witwatersrand, Johannesburg South Africa; and, National Priority Programme, National Health Laboratory Service, Johannesburg,, South Africa
Nelesh P. Govender, National Institute for Communicable Diseases, Division of the National Health Laboratory Service (NHLS), Johannesburg, South Africa; and, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg,, South Africa
Deborah K. Glencross, Department of Haematology and Molecular Medicine, University of the Witwatersrand, Johannesburg South Africa; and, National Priority Programme, National Health Laboratory Service, Johannesburg,, South Africa

Abstract

Background: Cryptococcal meningitis (CM) is a leading cause of mortality among HIV-positive South Africans. Reflex cryptococcal antigen (CrAg) testing of remnant plasma was offered as a pilot prior to implementation in October 2016 in KwaZulu-Natal province. The national reflex CrAg positivity was 5.4% compared to 7.3% for KwaZulu-Natal.

Objectives: The aim of this study was to interrogate CrAg positivity by health levels to identify hotspots.

Method: Data for the period October 2016 to June 2017 were analysed. Health district CrAg positivity and prevalence were calculated, with the latter using de-duplicated patient data. The district CrAg positivity and the number of CrAg-positive specimens per health facility were mapped using ArcGIS. For districts with the highest CrAg positivity, a sub-district CrAg positivity analysis was conducted.

Results: The provincial CrAg positivity was 7.6%. District CrAg positivity ranged from 5.7% (Ugu) to 9.6% (Umkhanyakude) with prevalence ranging from 5.5% (Ugu) to 9.7% (Umkhanyakude). The highest CrAg positivity was reported for the Umkhanyakude (9.6%) and King Cetswayo (9.5%) districts. In these two districts, CrAg positivity of 10% was noted in the Umhlabuyalingana (10.0%), Jozini (10.2%), uMhlathuze (10.5%) and Nkandla (10.8%) subdistricts. In these subdistricts, 135 CrAg-positive samples were reported for the Ngwelezane hospital followed by 41 and 43 at the Hlabisa and Manguzi hospitals respectively.

Conclusion: Cryptococcal antigen positivity was not uniformly distributed at either the district or sub-district levels, with identified facility hotspots in the Umkhanyakude and King Cetswayo districts. This study demonstrates the value of laboratory data to identify hotspots for planning programmatic interventions.


Keywords

HIV;CD4;CrAg;Cryptococcal Disease

Metrics

Total abstract views: 5477
Total article views: 5866

 

Crossref Citations

1. Prevalence of Cryptococcal Antigen and Outcomes in People With Human Immunodeficiency Virus in Honduras: A Cohort Study
Julio C Zuniga-Moya, Luis Enrique Romero-Reyes, Emilio Barrueto Saavedra, Sandra Montoya, Diana Varela, Mitchel Borjas, Alicia Cerna, Suyapa Bejarano, Paola Martinez, Karen Lujan, Karen Erazo, Isis Lainez, Luisamaria Pineda, David Yanes, Jane A O’Halloran, Andrej Spec
Open Forum Infectious Diseases  vol: 8  issue: 1  year: 2021  
doi: 10.1093/ofid/ofaa557

2. Implementation of the advanced HIV disease care package with point-of-care CD4 testing during tuberculosis case finding: A mixed-methods evaluation
Tinne Gils, Mashaete Kamele, Thandanani Madonsela, Shannon Bosman, Thulani Ngubane, Philip Joseph, Klaus Reither, Moniek Bresser, Erika Vlieghe, Tom Decroo, Irene Ayakaka, Lutgarde Lynen, Alastair Van Heerden, Lynn S. Zijenah
PLOS ONE  vol: 18  issue: 12  first page: e0296197  year: 2023  
doi: 10.1371/journal.pone.0296197

3. Newly implemented community CD4 service in Tshwaragano, Northern Cape province, South Africa, positively impacts result turn-around time
Lindi-Marie Coetzee, Naseem Cassim, Deborah K. Glencross
African Journal of Laboratory Medicine  vol: 11  issue: 1  year: 2022  
doi: 10.4102/ajlm.v11i1.1376

4. Using laboratory data to assess the impact of coronavirus (COVID-19) on reflex cryptococcal antigenaemia (CrAg) testing in South Africa
Naseem Cassim, Lindi Marie Coetzee, Manuel Pedro da Silva, Wendy Susan Stevens, Deborah Kim Glencross, Mergan Naidoo
PLOS ONE  vol: 18  issue: 9  first page: e0292062  year: 2023  
doi: 10.1371/journal.pone.0292062

5. Cryptococcal Antigenemia in South African Children Living With HIV
Alison Gifford, Rudzani Mashau, Ruth Mpembe, David Khanyile, Thabo Maota, Mbali Dube, Boitumelo Kgoale, Adilia Warris, Nelesh P. Govender
Pediatric Infectious Disease Journal  vol: 45  issue: 7  first page: 623  year: 2026  
doi: 10.1097/INF.0000000000005154

6. Retrospective Assessment of a National Reflex Cryptococcal Antigen Screening Program in South Africa Through Interlaboratory Comparison of Lateral Flow Assay Results
Nozuko P Blasich, Lindi M Coetzee, Charlotte Sriruttan, Daniel DeSanto, Gregory S Greene, Deborah K Glencross, Nelesh P Govender
Laboratory Medicine  vol: 53  issue: 6  first page: 614  year: 2022  
doi: 10.1093/labmed/lmac037